Pfizer: Global Research Awards for Nicotine Dependence - GRAND

Clinical research proposals should aim to increase the understanding of the mechanisms of tobacco and nicotine dependence and its treatment and fall into one of the following areas:
• Human laboratory (e.g., pharmacokinetics, pharmacodynamics, cravings, withdrawal);
• Pharmacotherapy of smoking cessation and relapse, and / or its interaction with behavioral support;
• Characterization of subtypes of smokers; suitability for appropriate interventions.
 
Funding: the intent of the program is to fund at least 6 awards of between US $50,000 and US $200,000 in value, totaling US $1.2 million. These awards are open to all investigators. We strongly encourage applications from junior investigators.